RxDoctor Payments Data

Lin Chen

Nurse Practitioner · Newark, NJNPI 1285168070

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 193 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 12.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $5,265, 2.9 times the $1,844 reported in 2021. Among nurse practitioner clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,719in general payments, 2019–2025

Across 193 payments — averaging $71.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Endologix LLC$2K
  • Cardiovascular Systems Inc.$2K
  • Shockwave Medical, Inc$2K
  • Stryker$1K
  • Inari Medical, Inc.$1K
  • Cagent Vascular Inc$1K
  • plus $5K from 31 others

What the payments were for

  • Food & beverage$13,719100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,719 in reported general payments places this provider in the 95th percentile of 2,138 nurse practitioner providers in New Jersey.

See all nurse practitioner providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban32$38,946
EntrestoSacubitril/Valsartan35$31,439
EliquisApixaban18$16,871
Repatha SureclickEvolocumab26$14,947
ClopidogrelClopidogrel Bisulfate113$1,327
Atorvastatin Calcium37$619
Metoprolol Succinate34$592
Carvedilol42$359
Losartan Potassium25$253
Furosemide31$151
Amlodipine Besylate28$118
Rosuvastatin Calcium11$117
Simvastatin13$72

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$102$38,94632 claims
NovartisEntresto$104$31,43935 claims
PfizerEliquis$100$16,87118 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,138 nurse practitioner providers in New Jersey.

Other nurse practitioner in Newark

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →